Department of Pathology, Renmin Hospital of Wuhan University, 238 Jiefang-Road, Wuchang District, Wuhan, 430060, People's Republic of China.
J Transl Med. 2024 Aug 29;22(1):799. doi: 10.1186/s12967-024-05609-6.
Artificial intelligence (AI) can acquire characteristics that are not yet known to humans through extensive learning, enabling to handle large amounts of pathology image data. Divided into machine learning and deep learning, AI has the advantage of handling large amounts of data and processing image analysis, consequently it also has a great potential in accurately assessing tumour microenvironment (TME) models. With the complex composition of the TME, in-depth study of TME contributes to new ideas for treatment, assessment of patient response to postoperative therapy and prognostic prediction. This leads to a review of the development of AI's application in TME assessment in this study, provides an overview of AI techniques applied to medicine, delves into the application of AI in analysing the quantitative and spatial location characteristics of various cells (tumour cells, immune and non-immune cells) in the TME, reveals the predictive prognostic value of TME and provides new ideas for tumour therapy, highlights the great potential for clinical applications. In addition, a discussion of its limitations and encouraging future directions for its practical clinical application is presented.
人工智能(AI)可以通过广泛的学习获得人类尚未了解的特征,从而能够处理大量的病理学图像数据。AI 分为机器学习和深度学习,具有处理大量数据和进行图像分析的优势,因此在准确评估肿瘤微环境(TME)模型方面也具有很大的潜力。由于 TME 的复杂组成,深入研究 TME 为治疗提供了新的思路,评估患者对术后治疗的反应和预后预测。因此,本研究对 AI 在 TME 评估中的应用进展进行了综述,概述了应用于医学的 AI 技术,深入探讨了 AI 在分析 TME 中各种细胞(肿瘤细胞、免疫和非免疫细胞)的定量和空间位置特征中的应用,揭示了 TME 的预测预后价值,并为肿瘤治疗提供了新思路,突出了其在临床应用中的巨大潜力。此外,还讨论了其局限性和鼓励其实际临床应用的未来方向。